These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3898566)
1. [A review of selected cytostatic agents based on platinum]. Hejl J; Kiss F; Hejlová N Vnitr Lek; 1985 Jun; 31(6):577-84. PubMed ID: 3898566 [No Abstract] [Full Text] [Related]
2. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]
3. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin. Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237 [TBL] [Abstract][Full Text] [Related]
4. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation. Presnov MA; Konovalova AL Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804 [TBL] [Abstract][Full Text] [Related]
5. Whither carboplatin? A replacement for or an alternative to cisplatin? Gil A J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520 [No Abstract] [Full Text] [Related]
6. Resistance to platinum compounds: mechanisms and beyond. Kelley SL; Rozencweig M Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1135-40. PubMed ID: 2670584 [No Abstract] [Full Text] [Related]
7. Whither carboplatin?--A replacement for or an alternative to cisplatin? Von Hoff DD J Clin Oncol; 1987 Feb; 5(2):169-71. PubMed ID: 3543240 [No Abstract] [Full Text] [Related]
8. [Experimental study on the anti-tumor effects of CDDP derivatives on head and neck squamous cell carcinoma cell lines]. Tsukuda M; Yoshida T; Kubota A; Yanoma S; Watanabe S; Takahashi K; Ono T; Sawaki S Gan To Kagaku Ryoho; 1988 Sep; 15(9):2811-4. PubMed ID: 3415274 [No Abstract] [Full Text] [Related]
11. Comparing cisplatin and carboplatin. Neijt JP; van Houwelingen JC J Natl Cancer Inst; 1990 Mar; 82(5):434-5. PubMed ID: 2406453 [No Abstract] [Full Text] [Related]
12. Platinum compounds in children with cancer: toxicity and clinical management. Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902 [TBL] [Abstract][Full Text] [Related]
13. Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin. Carter SK Cancer Treat Rev; 1987 Dec; 14(3-4):179-85. PubMed ID: 3326662 [No Abstract] [Full Text] [Related]
14. Carboplatin. Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623 [No Abstract] [Full Text] [Related]
16. Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma--a word of caution. McGuire WP; Abeloff MD J Natl Cancer Inst; 1989 Oct; 81(19):1438-9. PubMed ID: 2674458 [No Abstract] [Full Text] [Related]
17. In vivo and in vitro effectivity of some platinum complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026 [TBL] [Abstract][Full Text] [Related]
18. Advances in platinum chemotherapeutics. Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453 [TBL] [Abstract][Full Text] [Related]
19. Carboplatin versus cisplatin. Tighe M; Goodman S Lancet; 1988 Dec; 2(8624):1372-3. PubMed ID: 2904096 [No Abstract] [Full Text] [Related]
20. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts. Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]